Who are Follitropin Epsilon's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): rFSH drug dose, fix dose r-FSH (Gonal-f), Guo Na Fen (Gonal-F), Ovarian Stimulation with rFSH, Gonal-f® RFF, rFSH (Gonal®,.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/follitropin-epsilon.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Follitropin Epsilon — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Follitropin Epsilon (Follitropin Epsilon) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Gonadotropin. Area: Reproductive Health.

phase 2 Gonadotropin FSH receptor Reproductive Health Small molecule Live · refreshed every 30 min

Target snapshot

Follitropin Epsilon (Follitropin Epsilon) — Glycotope GmbH. Follitropin Epsilon is a recombinant human follicle-stimulating hormone used to stimulate follicular growth in the ovaries.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Follitropin Epsilon TARGET	Follitropin Epsilon	Glycotope GmbH	phase 2	Gonadotropin	FSH receptor
rFSH drug dose	rFSH drug dose	Nina la Cour Freiesleben	marketed	Gonadotropin	FSH receptor (FSHR)
fix dose r-FSH (Gonal-f)	fix dose r-FSH (Gonal-f)	Sisli Hamidiye Etfal Training and Research Hospital	marketed	Gonadotropin	FSH receptor (FSHR)
Guo Na Fen (Gonal-F)	Guo Na Fen (Gonal-F)	LG Chem	marketed	Gonadotropin; recombinant FSH	FSH receptor (FSHR)
Ovarian Stimulation with rFSH	Ovarian Stimulation with rFSH	Fundación Santiago Dexeus Font	marketed	Gonadotropin	FSH receptor (FSHR)
Gonal-f® RFF	Gonal-f® RFF	Fertility Biotech AG	marketed	Gonadotropin; recombinant FSH	FSH receptor (FSHR)
rFSH (Gonal®,	rFSH (Gonal®,	Instituto Valenciano de Infertilidad, IVI VALENCIA	marketed	Gonadotropin	FSH receptor (FSHR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Gonadotropin class)

Instituto Valenciano de Infertilidad, IVI VALENCIA · 4 drugs in this class
Sisli Hamidiye Etfal Training and Research Hospital · 3 drugs in this class
Organon and Co · 3 drugs in this class
Fundación Santiago Dexeus Font · 3 drugs in this class
Merck KGaA · 2 drugs in this class
Nina la Cour Freiesleben · 2 drugs in this class
IVI Madrid · 2 drugs in this class
Dunamenti REK Istenhegyi IVF Center · 1 drug in this class
D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology · 1 drug in this class
Azienda USL Modena · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Follitropin Epsilon — Competitive Intelligence Brief. https://druglandscape.com/ci/follitropin-epsilon. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab